The Cuban vaccine against the Haemophilus influenzae B, the first of its kind obtained from synthetic antigens in the world, received the Gold Medal granted by the World Intellectual Property Organization.
The acknowledgement was received in this capital by Vicente Verez, director of the Center for Studies on Synthetic Antigens, which is attached to the Faculty of Chemistry of the University of Havana. Verez is also one of the creators of the vaccine.
According to experts, the vaccine was made using new procedures and a patented technology.
All Cuban children still on milk benefit from immunization against Haemophilus influenzae B, which kills 500,000 children under five years of age every year in the world.
The vaccine was developed in conjunction with the Genetic Engineering and Biotechnology Center, the Centro Nacional de Biopreparados, the Finlay Institute and the Pedro KourÝ Tropical Medicine Institute.
This is the sixth time that the World Intellectual Property Organization grants an award to Cuban products.